E-LIB Suche - Ergebnisse für: Valkema, Maria J.

1

External validation of 18F-FDG PET-based radiomic models on..:

Valkema, Maria J. ; Beukinga, Roelof J. ; Chatterjee, Avishek...
Nuclear Medicine Communications. 44 (2023) 8 - p. 709-718 , 2023

Link: https://doi.org/10.1097/..

2

18F-FDG PET/MRI for restaging esophageal cancer after neoad..:

Valkema, Maria J. ; de Lussanet de la Sablonière, Quido G. ; Valkema, Roelf...
Nuclear Medicine Communications. 45 (2023) 2 - p. 128-138 , 2023

Link: https://doi.org/10.1097/..

3

The effectiveness of neoadjuvant chemoradiotherapy in oesop..:

Valkema, Maria J ; Vos, Anne‐Marie ; van der Post, Rachel S...
The Journal of Pathology: Clinical Research. 9 (2023) 4 - p. 322-335 , 2023

Link: https://doi.org/10.1002/..

4

A prospective cohort study on active surveillance after neo..:

van der Zijden, Charlène J. ; Lagarde, Sjoerd M. ; Hermus, Merel...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

283. 18F-FDG PET/MRI FOR RESTAGING ESOPHAGEAL CANCER AFTER ..:

Valkema, Maria ; Sablonière, Quido de Lussanet ; Valkema, Roelf...
Diseases of the Esophagus. 36 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

6

Active surveillance of oesophageal cancer after response to..:

Valkema, Maria J ; Spaander, Manon C W ; Boonstra, Jurjen J...
British Journal of Surgery. 110 (2023) 10 - p. 1381-1386 , 2023

Link: https://doi.org/10.1093/..

7

Shrinkage versus fragmentation response in neoadjuvantly tr..:

Graham Martinez, Cristina ; Kus Öztürk, Sonay ; Al‐Kaabi, Ali...
Histopathology. 80 (2022) 6 - p. 982-994 , 2022

Link: https://doi.org/10.1111/..

8

PS02.064: ACCURACY OF F-18-FDG-PET/CT IN MONITORING TUMOUR ..:

Valkema, Maria ; Noordman, B ; Wijnhoven, Bas P L...
Diseases of the Esophagus. 31 (2018) Supplement_1 - p. 138-139 , 2018

Link: https://doi.org/10.1093/..

9

RA07.06: BASELINE FDG-PET/CT PARAMETERS AS PREDICTOR FOR RE..:

Valkema, Maria ; Noordman, B ; Wijnhoven, Bas P L...
Diseases of the Esophagus. 31 (2018) Supplement_1 - p. 35-35 , 2018

Link: https://doi.org/10.1093/..

10

266. EXTENSION OF FDG-PET-BASED RADIOMIC MODELS ON IDENTIFI..:

Valkema, Maria Joanna ; Beukinga, Roelof ; Chatterjee, Avishek...
Diseases of the Esophagus. 35 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

11

453. THE EFFECTIVITY OF NEOADJUVANT CHEMORADIOTHERAPY IN ES..:

Valkema, Maria Joanna ; Vos, AM ; van der Post, RS...
Diseases of the Esophagus. 35 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

12

A prospective cohort study on active surveillance after neo..:

van der Zijden, Charlène J ; Lagarde, Sjoerd M ; Hermus, Merel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084614/. , 2023

Link: http://www.ncbi.nlm.nih...

13

External validation of 18 F-FDG PET-based radiomic models o..:

Valkema, Maria J ; Beukinga, Roelof J ; Chatterjee, Avishek...
https://research.rug.nl/en/publications/4c106951-ecca-4fbb-9f65-3cf9434accea. , 2023

Link: https://hdl.handle.net/1..

14

The effectiveness of neoadjuvant chemoradiotherapy in oesop..:

Valkema, Maria J ; Vos, Anne‐Marie ; van der Post, Rachel S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240149/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Optimization of detection of residual disease after neoadju..:

Valkema, Maria J ; Doukas, Michail ; Spaander, Manon C.W...
Valkema , M J , Doukas , M , Spaander , M C W , Valkema , R , Woodruff , H C & Van Lanschot , J J B 2021 , ' Optimization of detection of residual disease after neoadjuvant therapy in patients with esophageal cancer ' , Annals of Esophagus , vol. 3 , 6 . https://doi.org/10.21037/aoe-2020-02. , 2021

Link: https://pure.eur.nl/en/p..